Home › Funds › COMPASS CAPITAL MANAGEMENT, INC › BSX
COMPASS CAPITAL MANAGEMENT, INC position in BSX
BOSTON SCIENTIFIC CORP · Health Care
COMPASS CAPITAL MANAGEMENT, INC reported holding 1,004,548 shares of BSX (BOSTON SCIENTIFIC CORP) in its Q3 2026 13F filing — a position valued at US$43.8M, representing 2.55% of its reported portfolio and ranking #24 among its reported holdings. COMPASS CAPITAL MANAGEMENT, INC has disclosed BSX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How COMPASS CAPITAL MANAGEMENT, INC's BSX position evolved
COMPASS CAPITAL MANAGEMENT, INC first disclosed a stake in BSX in Q4 2025 at 584,068 shares (US$55.7M). Across 4 filings, COMPASS CAPITAL MANAGEMENT, INC increased the stake 3 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 1,004,548 shares valued at US$43.8M — an increase of 145,018 shares quarter over quarter..
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2025 | 584.07K | $55.69M | New |
| Q1 2026 | 710.87K | $44.61M | Add |
| Q2 2026 | 859.53K | $36.68M | Add |
| Q3 2026 | 1.00M | $43.85M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About BSX and 13F data
BSX (BOSTON SCIENTIFIC CORP) is a Health Care company. 18 other funds we track also report a position in BSX — the largest reported positions include PRIMECAP MANAGEMENT CO/CA/ (US$2.56B), MFS Investment Management (US$2.29B), D. E. Shaw & Co (US$1.16B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding BSX
- PRIMECAP MANAGEMENT CO/CA/ 58.62M sh · $2.56B · Q3 2026
- MFS Investment Management 43.05M sh · $2.29B · Q3 2026
- D. E. Shaw & Co 27.27M sh · $1.16B · Q2 2026
- Janus Henderson Group 16.50M sh · $1.04B · Q1 2026
- Arrowstreet Capital 23.29M sh · $994.18M · Q2 2026
More on COMPASS CAPITAL MANAGEMENT, INC
FAQ
How long has COMPASS CAPITAL MANAGEMENT, INC held BSX?
COMPASS CAPITAL MANAGEMENT, INC has disclosed BSX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.
What is COMPASS CAPITAL MANAGEMENT, INC's current position in BSX?
As of Q3 2026, COMPASS CAPITAL MANAGEMENT, INC holds 1.00M shares of BSX (BOSTON SCIENTIFIC CORP), valued at $43.85M, representing 2.55% of its reported portfolio and ranking #24.
Has COMPASS CAPITAL MANAGEMENT, INC been buying or selling BSX?
In the latest 13F filing (Q3 2026), COMPASS CAPITAL MANAGEMENT, INC increased its position in BSX.
Which other funds hold BSX?
Other major institutional holders of BSX include PRIMECAP MANAGEMENT CO/CA/, MFS Investment Management, D. E. Shaw & Co, among 18 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.